platinum has been researched along with zoledronic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cormio, G; Cuccovillo, A; Fattizzi, N; Loizzi, V; Selvaggi, L | 1 |
| Kang, S; Lin, Y; Lv, X; Song, C; Yu, Y; Zhang, J | 1 |
2 review(s) available for platinum and zoledronic acid
| Article | Year |
|---|---|
Two cases of endometrial cancer diagnosis associated with bone metastasis.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Cervical Vertebrae; Cyclophosphamide; Diphosphonates; Doxorubicin; Endometrial Neoplasms; Fatal Outcome; Female; Humans; Imidazoles; Middle Aged; Platinum; Spinal Neoplasms; Tibia; Zoledronic Acid | 2006 |
Efficacy and safety of neoadjuvant therapy for triple-negative breast cancer: a Bayesian network meta-analysis.
Topics: Albumin-Bound Paclitaxel; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; B7-H1 Antigen; Bayes Theorem; Bevacizumab; Humans; Ligands; Neoadjuvant Therapy; Network Meta-Analysis; Platinum; Programmed Cell Death 1 Receptor; Taxoids; Triple Negative Breast Neoplasms; Zoledronic Acid | 2022 |